Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
Sign Up to like & getrecommendations! Published in 2019 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-019-0513-4
Abstract: BackgroundIn oncology clinical development, objective response rate, disease control rate and early tumor size changes are commonly used as efficacy metrics for early decision-making. However, for immunotherapy trials, it is unclear whether these early efficacy… read more here.
Keywords: efficacy metrics; size changes; tumor size; tumor ... See more keywords